Prostate Cancer Clinical Trials
Find clinical trials for prostate cancer. Search for prostate cancer clinical trials in different cities and states across the United States.
18F-DCFPyL18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05155046
Conditions
Localized Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
18F-DCFPyL
Radiomics EvaluationCan MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour
Sponsor:
Nova Scotia Health Authority
Location:
Code:
NCT05024162
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
MRT Accuracy
MRT Stability
HDR BrachytherapyMulti-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Sponsor:
British Columbia Cancer Agency
Location:
Code:
NCT06200974
Conditions
Localized Prostate Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
High dose rate prostate brachytherapy
NX-1607A Study of NX-1607 in Adults With Advanced Malignancies
Sponsor:
Nurix Therapeutics, Inc.
Location:
Code:
NCT05107674
Conditions
Ovarian Cancer, Epithelial
Gastric Cancer
GastroEsophageal Junction (GEJ) Cancer
Head and Neck Squamous Cell Carcinoma
Metastatic or Unresectable Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NX-1607
Paclitaxel
EnzalutamideDetecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.
Sponsor:
CHU de Quebec-Universite Laval
Location:
Code:
NCT04655365
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Enzalutamide capsule
FAPI PET/MRIUsing FAPI PET/MRI to Evaluate Prostate Cancer
Sponsor:
University of Wisconsin, Madison
Location:
Code:
NCT06675357
Conditions
Prostate Cancer Metastatic Disease
Prostate Cancers
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FAPI
Positron Emission Tomography (PET)
Magnetic Resonance Imaging
Nivolumab, Ipilimumab, CabozantinibTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03866382
Conditions
Bladder Adenocarcinoma
Bladder Clear Cell Adenocarcinoma
Bladder Mixed Adenocarcinoma
Bladder Neuroendocrine Carcinoma
Bladder Small Cell Neuroendocrine Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Scan
Cabozantinib S-malate
Computed Tomography
Echocardiography Test
Cardiovascular InterventionA RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Sponsor:
McMaster University
Location:
Code:
NCT03127631
Conditions
Prostate Cancer
Cardiovascular Disease
Eligibility Criteria
Sex: Male
Age: 45+
Healthy Volunteers: Not accepted
Interventions
Nutrition
Exercise
Smoking cessation
Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)
ACE inhibitor
XL092XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
University of Utah
Location:
Code:
NCT06568562
Conditions
Metastatic Castration-resistant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
XL092